AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
IND application filed for chlamydia vaccine.(investigational new drug)
2003 MAR 6 - (NewsRx.com & NewsRx.net) -- Antex Biologics Inc. (AMEX:ANX) has filed an initial investigational new drug (IND) application for its TracVax vaccine with the U.S. Food and Drug Administration (FDA).
TracVax is a recombinant subunit vaccine designed to prevent and treat infections caused by Chlamydia trachomatis. Chlamydia is the world's most prevalent sexually transmitted disease and can lead to pelvic inflammatory disease, infertility, and blindness. Chlamydia is the leading cause of infertility and blindness in many countries, including the United States, where annually more than 20,000 women are diagnosed as infertile as a direct result of Chlamydia infection.
This Phase I clinical trial will be an open-label, randomized trial designed to assess the ...
- Antex Files Chlamydia Investigational New Drug Application With FDA - STD...
- Press release article from: PR Newswire February 3, 2003 700+ words
...it has filed an initial Investigational New Drug Application for its...that the vaccine generates immune responses that protect against infection...infertility. Based on the immune responses, including cytokine release...and Th2 (humoral) type immune responses. The ...
- FDA Approves Antex Biologics' Investigational New Drug Application (INDA) For...
- Press release article from: PR Newswire January 27, 2003 700+ words
...Biologics Inc. today announced that its Investigational New Drug Application (INDA) for its...two trials will focus on mucosal immune responses as correlates of protection, as...events, and generated anticipated immune responses to H. pylori in both uninfected...
- Zengen, Inc. Announces Investigational New Drug Filing To Treat Vaginal Yeast...
- Press release article from: PR Newswire October 23, 2002 700+ words
...Zengen, Inc. announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug...shown that our peptides inhibit inflammation and modulate immune responses, while at the same time have demonstrated efficacy in...
- Medarex Announces Allowance of Investigational New Drug Application for...
- Press release article from: PR Newswire August 5, 2008 700+ words
...Medarex, Inc. announced today the allowance of an investigational new drug application (IND) filed with the U.S. Food...targets the PD-L1 pathway to promote enhanced T-cell immune responses against cancer and reverse T-cell inactivation in chronic...
- Ono and Medarex Announce Allowance of Investigational New Drug Application for...
- Press release article from: PR Newswire August 1, 2006 700+ words
...and Medarex, Inc. announced today the allowance of an investigational new drug application (IND) filed with the U.S. Food...an important role in tumor evasion and escape from host immune responses and may also promote the persistence of certain chronic...
- MedImmune files IND for combination vacc.(Investigational New Drug )(Brief...
- Newspaper article from: Pharma Marketletter January 31, 2005 700+ words
MedImmune has filed an Investigational New Drug application with the US Food and Drug Administration...indicating that the combination vaccine elicited protective immune responses to RSV and PIV-3, two leading causes of pediatric respiratory...
- Ono and Medarex Announce Allowance of Investigational New Drug Application for...
- Press release article from: PR Newswire October 29, 2007 700+ words
...and Medarex, Inc. announced today the allowance of an investigational new drug application (IND) filed with the U.S. Food...HCV, may use the PD-1 pathway to evade host adaptive immune responses (which protect the host from both harmful pathogens and...
- CancerVax Submits IND Application for Canvaxin.(investigational new drug)
- Newspaper article from: Immunotherapy Weekly January 30, 2002 700+ words
...NewsRx.net) -- CancerVax Corp. has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug...indicated that the Canvaxin vaccine induced specific immune responses that correlated with survival in patients with advanced...
